Rxcurve
Medicare Part B payment limits Effective October 1 – December 31, 2026 Posted by CMS September 17, 2026
HCPCS Q9991 · per Less than or equal to 100 MG

Buprenorph xr 100 mg or less

Products billed under this code include Sublocade.

Payment limit per Less than or equal to 100 MG, by effective quarter, 1Q21 to 4Q26. Gaps mean the code was not in that quarter’s file, or CMS gave no payment limit.

Products billed under Q9991

From the 4Q26 NDC–HCPCS crosswalk. “Limit / pkg” is the 4Q26 payment limit times the billing units in one package.

ProductLabelerNDCUnits / pkgLimit / pkg
Sublocade Indivior Inc. 12496-0100-01 1 $2,060.132

Every quarter

QuarterPayment limitChangeBilling unitDescriptionSource file
4Q26 $2,060.132 −$8.023 Less than or equal to 100 MG Buprenorph xr 100 mg or less v1, posted September 17, 2026
3Q26 $2,068.155 +$71.598 Less than or equal to 100 MG Buprenorph xr 100 mg or less v1, posted September 15, 2026
2Q26 $1,996.557 −$1.976 Less than or equal to 100 MG Buprenorph xr 100 mg or less v1, posted September 15, 2026
1Q26 $1,998.533 −$17.89 Less than or equal to 100 MG Buprenorph xr 100 mg or less v1, posted September 15, 2026
4Q25 $2,016.423 +$39.871 Less than or equal to 100 MG Buprenorph xr 100 mg or less v1, posted September 8, 2026
3Q25 $1,976.552 +$51.321 Less than or equal to 100 MG Buprenorph xr 100 mg or less v1, posted March 10, 2026
2Q25 $1,925.231 −$6.581 Less than or equal to 100 MG Buprenorph xr 100 mg or less v1, posted March 10, 2026
1Q25 $1,931.812 −$11.246 Less than or equal to 100 MG Buprenorph xr 100 mg or less v1, posted December 19, 2025
4Q24 $1,943.058 −$18.501 Less than or equal to 100 MG Buprenorph xr 100 mg or less v1, posted June 11, 2025
3Q24 $1,961.559 +$86.657 Less than or equal to 100 MG Buprenorph xr 100 mg or less v1, posted June 11, 2025
2Q24 $1,874.902 −$12.211 Less than or equal to 100 MG Buprenorph xr 100 mg or less v1, posted March 11, 2025
1Q24 $1,887.113 +$0.136 Less than or equal to 100 MG Buprenorph xr 100 mg or less v1, posted December 19, 2024
4Q23 $1,886.977 +$0.61 Less than or equal to 100 MG Buprenorph xr 100 mg or less v1, posted October 10, 2024
3Q23 $1,886.367 +$92.52 Less than or equal to 100 MG Buprenorph xr 100 mg or less v1, posted June 5, 2024
2Q23 $1,793.847 −$31.986 Less than or equal to 100 MG Buprenorph xr 100 mg or less v1, posted February 23, 2024
1Q23 $1,825.833 −$16.343 Less than or equal to 100 MG Buprenorph xr 100 mg or less v1, posted December 6, 2023
4Q22 $1,842.176 −$16.434 Less than or equal to 100 MG Buprenorph xr 100 mg or less v1, posted June 22, 2023
3Q22 $1,858.61 +$77.301 Less than or equal to 100 MG Buprenorph xr 100 mg or less v1, posted June 9, 2023
2Q22 $1,781.309 −$5.723 Less than or equal to 100 MG Buprenorph xr 100 mg or less v1, posted December 14, 2022
1Q22 $1,787.032 −$9.766 Less than or equal to 100 MG Buprenorph xr 100 mg or less v1, posted June 8, 2022
4Q21 $1,796.798 −$19.853 Less than or equal to 100 MG Buprenorph xr 100 mg or less v1, posted June 2, 2022
3Q21 $1,816.651 +$80.111 Less than or equal to 100 MG Buprenorph xr 100 mg or less v1, posted June 2, 2022
2Q21 $1,736.54 −$0.717 Less than or equal to 100 MG Buprenorph xr 100 mg or less v1, posted March 1, 2022
1Q21 $1,737.257 – Less than or equal to 100 MG Buprenorph xr 100 mg or less v1, posted December 10, 2021

“Change” is the difference from the previous quarter, shown only when both quarters have a payment limit and the billing unit is the same. “vs. last quarter” and “vs. a year ago” follow the same rule.

CMS source files